• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传检测有助于对小脑蚓部缺陷胎儿进行咨询。

Genetic tests aid in counseling of fetuses with cerebellar vermis defects.

机构信息

Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

Eugenic and Perinatal Institute, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

出版信息

Prenat Diagn. 2020 Sep;40(10):1228-1238. doi: 10.1002/pd.5732. Epub 2020 May 28.

DOI:10.1002/pd.5732
PMID:32386258
Abstract

OBJECTIVE

To assess the value of chromosome microarray analysis (CMA) and whole exome sequencing (WES) in fetuses with cerebellar vermis defects (CVD).

METHODS

From 2013 to 2019, we performed CMA on 43 fetuses with CVD, who were divided into cerebellar vermis hypoplasia (CVH) group and Dandy-Walker malformation (DWM) group according to morphological subtypes. Subsequently, WES was performed on 19 fetuses with normal CMA results to identify diagnostic genetic variants (DGVs).

RESULTS

Chromosome aneuploidies and clinically significant copy number variants were identified in 23.3% (10/43) of fetuses, and a significantly higher positive rate was found in fetuses with multiple compared with isolated malformations (36% vs 5.6%, P = .028). STAG2 genes related to Xq25 duplication syndrome was possibly a novel candidate gene for CVD. WES detected eight DGVs in seven genes among the 19 fetuses tested. Autosomal recessive ciliopathies (4/8) caused by TMEM231, CSPP1, and CEP290 mutations, were the most frequent monogenetic diseases, followed by Opitz GBBB syndrome (2/8) caused by MID1 and SPECC1L variants.

CONCLUSION

The combined use of CMA and WES has the potential to provide genetic diagnoses in 42% (18/43) of fetal CVD. WES should be offered when CMA results are normal.

摘要

目的

评估染色体微阵列分析(CMA)和全外显子测序(WES)在小脑蚓部缺陷(CVD)胎儿中的应用价值。

方法

2013 年至 2019 年,我们对 43 例 CVD 胎儿进行了 CMA 分析,根据形态学亚型将其分为小脑蚓部发育不良(CVH)组和 Dandy-Walker 畸形(DWM)组。随后,对 19 例 CMA 结果正常的胎儿进行 WES,以鉴定诊断性遗传变异(DGVs)。

结果

23.3%(10/43)的胎儿中发现了染色体非整倍体和临床意义上的拷贝数变异,多发畸形胎儿的阳性率明显高于单发畸形胎儿(36%比 5.6%,P=0.028)。Xq25 重复综合征相关的 STAG2 基因可能是 CVD 的一个新候选基因。在 19 例检测的胎儿中,WES 在 7 个基因中检测到 8 个 DGVs。常染色体隐性纤毛病(4/8)由 TMEM231、CSPP1 和 CEP290 突变引起,是最常见的单基因疾病,其次是 Opitz GBBB 综合征(2/8)由 MID1 和 SPECC1L 变异引起。

结论

CMA 和 WES 的联合应用有可能为 42%(18/43)的胎儿 CVD 提供遗传诊断。当 CMA 结果正常时,应进行 WES。

相似文献

1
Genetic tests aid in counseling of fetuses with cerebellar vermis defects.遗传检测有助于对小脑蚓部缺陷胎儿进行咨询。
Prenat Diagn. 2020 Sep;40(10):1228-1238. doi: 10.1002/pd.5732. Epub 2020 May 28.
2
Prenatal diagnosis of posterior fossa anomalies: Additional value of chromosomal microarray analysis in fetuses with cerebellar hypoplasia.产前诊断后颅窝异常:染色体微阵列分析在小脑发育不良胎儿中的附加价值。
Prenat Diagn. 2018 Jan;38(2):91-98. doi: 10.1002/pd.5190. Epub 2018 Jan 10.
3
Comprehensive evaluation of genetic variants using chromosomal microarray analysis and exome sequencing in fetuses with congenital heart defect.采用染色体微阵列分析和外显子组测序对先天性心脏病胎儿的遗传变异进行综合评估。
Ultrasound Obstet Gynecol. 2021 Sep;58(3):377-387. doi: 10.1002/uog.23532.
4
Prenatal exome sequencing analysis in fetuses with central nervous system anomalies.胎儿中枢神经系统畸形的产前外显子组测序分析。
Ultrasound Obstet Gynecol. 2023 Nov;62(5):721-726. doi: 10.1002/uog.26254.
5
Hindbrain morphometry and choroid plexus position in differential diagnosis of posterior fossa cystic malformations.小脑形态测量和脉络丛位置在后颅窝囊性畸形鉴别诊断中的作用。
Ultrasound Obstet Gynecol. 2019 Aug;54(2):207-214. doi: 10.1002/uog.20120.
6
Prenatal diagnosis and outcomes in fetuses with duplex kidney.胎儿重复肾的产前诊断及结局。
Int J Gynaecol Obstet. 2024 Jul;166(1):353-359. doi: 10.1002/ijgo.15344. Epub 2024 Jan 8.
7
Genetic Examination for Fetuses with Increased Fetal Nuchal Translucency by Genomic Technology.应用基因组技术对胎儿颈部透明带增厚的胎儿进行基因检测。
Cytogenet Genome Res. 2020;160(2):57-62. doi: 10.1159/000506095. Epub 2020 Feb 8.
8
Exome sequencing as first-tier test for fetuses with severe central nervous system structural anomalies.外显子组测序作为一线检测手段用于严重中枢神经系统结构异常的胎儿。
Ultrasound Obstet Gynecol. 2022 Jul;60(1):59-67. doi: 10.1002/uog.24885.
9
Whole-exome sequencing in the evaluation of fetal structural anomalies: a prospective cohort study.全外显子组测序在胎儿结构畸形评估中的应用:一项前瞻性队列研究。
Lancet. 2019 Feb 23;393(10173):758-767. doi: 10.1016/S0140-6736(18)32042-7. Epub 2019 Jan 31.
10
Optimal prenatal genetic diagnostic approach for posterior fossa malformation: karyotyping, copy number variant testing, or whole-exome sequencing?后颅窝畸形的最佳产前基因诊断方法:核型分析、拷贝数变异检测还是全外显子测序?
Eur J Med Res. 2024 Jul 31;29(1):397. doi: 10.1186/s40001-024-01993-3.

引用本文的文献

1
Optimal prenatal genetic diagnostic approach for posterior fossa malformation: karyotyping, copy number variant testing, or whole-exome sequencing?后颅窝畸形的最佳产前基因诊断方法:核型分析、拷贝数变异检测还是全外显子测序?
Eur J Med Res. 2024 Jul 31;29(1):397. doi: 10.1186/s40001-024-01993-3.
2
Advancing fetal diagnosis and prognostication using comprehensive prenatal phenotyping and genetic testing.利用全面的产前表型分析和基因检测推进胎儿诊断和预后评估。
Pediatr Res. 2024 Jun 27. doi: 10.1038/s41390-024-03343-9.
3
Prenatal Genome-Wide Sequencing analysis (Exome or Genome) in detecting pathogenic Single Nucleotide Variants in fetal Central Nervous System Anomalies: systematic review and meta-analysis.
产前全基因组测序分析(外显子或基因组)在检测胎儿中枢神经系统异常中的致病性单核苷酸变异:系统评价和荟萃分析。
Eur J Hum Genet. 2024 Jul;32(7):759-769. doi: 10.1038/s41431-024-01590-2. Epub 2024 Mar 15.
4
Monogenic conditions and central nervous system anomalies: A prospective study, systematic review and meta-analysis.单基因疾病与中枢神经系统异常:一项前瞻性研究、系统综述和荟萃分析。
Prenat Diagn. 2024 Apr;44(4):422-431. doi: 10.1002/pd.6466. Epub 2023 Dec 6.
5
Identification of novel gene splice variants and pathological findings in a fetus with Meckel Syndrome.梅克尔综合征胎儿中新基因剪接变体的鉴定及病理发现
Front Genet. 2023 Sep 6;14:1252873. doi: 10.3389/fgene.2023.1252873. eCollection 2023.
6
Fetal Cerebellar Area: Ultrasound Reference Ranges at 13-39 Weeks of Gestation.胎儿小脑面积:妊娠13至39周的超声参考范围。
J Clin Med. 2023 Jun 16;12(12):4080. doi: 10.3390/jcm12124080.
7
Pathogenic/likely pathogenic copy number variations and regions of homozygosity in fetal central nervous system malformations.胎儿中枢神经系统畸形中的致病性/可能致病性拷贝数变异和纯合区域
Arch Gynecol Obstet. 2023 Dec;308(6):1723-1735. doi: 10.1007/s00404-022-06866-w. Epub 2022 Dec 5.
8
Molecular Approaches in Fetal Malformations, Dynamic Anomalies and Soft Markers: Diagnostic Rates and Challenges-Systematic Review of the Literature and Meta-Analysis.胎儿畸形、动态异常和软指标的分子检测方法:诊断率与挑战——文献系统综述与荟萃分析
Diagnostics (Basel). 2022 Feb 23;12(3):575. doi: 10.3390/diagnostics12030575.
9
Exome sequencing as first-tier test for fetuses with severe central nervous system structural anomalies.外显子组测序作为一线检测手段用于严重中枢神经系统结构异常的胎儿。
Ultrasound Obstet Gynecol. 2022 Jul;60(1):59-67. doi: 10.1002/uog.24885.
10
Diagnostic yield of exome sequencing for prenatal diagnosis of fetal structural anomalies: A systematic review and meta-analysis.外显子组测序在产前诊断胎儿结构畸形中的诊断效能:系统评价和荟萃分析。
Prenat Diagn. 2022 May;42(6):662-685. doi: 10.1002/pd.6115. Epub 2022 May 7.